Mehmood Y, Shahid H, Ahmed S, Khursheed A, Jamshaid T, Jamshaid M
Sci Rep. 2024; 14(1):23866.
PMID: 39394201
PMC: 11470002.
DOI: 10.1038/s41598-024-72951-6.
Kushary S, Cao X, Ghosh T, Roy P
Sci Rep. 2024; 14(1):21897.
PMID: 39300232
PMC: 11413237.
DOI: 10.1038/s41598-024-71251-3.
Kollabathula S, Venkatachalam K, Divya K, Guruprasad P, Nayar P
Indian Dermatol Online J. 2024; 15(3):449-453.
PMID: 38845675
PMC: 11152502.
DOI: 10.4103/idoj.idoj_742_23.
Khan S, Bilal H, Khan M, Fang W, Chang W, Yin B
Front Immunol. 2024; 15:1372693.
PMID: 38605952
PMC: 11007146.
DOI: 10.3389/fimmu.2024.1372693.
Francesco C
Bioinformation. 2023; 19(6):679-684.
PMID: 37885781
PMC: 10598368.
DOI: 10.6026/97320630019679.
Rehmannioside A Inhibits TRAF6/MAPK Pathway and Improves Psoriasis by Interfering with the Interaction of HaCaT Cells with IL-17A.
Yuan L, Cao C
Clin Cosmet Investig Dermatol. 2023; 16:2585-2596.
PMID: 37752969
PMC: 10519428.
DOI: 10.2147/CCID.S430621.
The therapeutic effect of glycyrrhizic acid compound ointment on imiquimod-induced psoriasis-like disease in mice.
Zhang Y, Wang Q, Sun S, Jiang L
PLoS One. 2023; 18(8):e0290637.
PMID: 37643205
PMC: 10464954.
DOI: 10.1371/journal.pone.0290637.
Serum LL-37 and inflammatory cytokines levels in psoriasis.
Lao J, Xie Z, Qin Q, Qin R, Li S, Yuan Y
Immun Inflamm Dis. 2023; 11(3):e802.
PMID: 36988247
PMC: 10013411.
DOI: 10.1002/iid3.802.
Neutrophils inhibit γδ T cell functions in the imiquimod-induced mouse model of psoriasis.
Costa S, Bevilacqua D, Caveggion E, Gasperini S, Zenaro E, Pettinella F
Front Immunol. 2022; 13:1049079.
PMID: 36466913
PMC: 9709482.
DOI: 10.3389/fimmu.2022.1049079.
Potential Pathogenetic Role of Antimicrobial Peptides Carried by Extracellular Vesicles in an in vitro Psoriatic Model.
Capriotti L, Iuliano M, Lande R, Frasca L, Falchi M, Rosa P
J Inflamm Res. 2022; 15:5387-5399.
PMID: 36147689
PMC: 9488619.
DOI: 10.2147/JIR.S373150.
Serum Levels of Tumor Necrosis Factor - alpha in Patients With Psoriasis.
Ovcina-Kurtovic N, Kasumagic-Halilovic E
Mater Sociomed. 2022; 34(1):40-43.
PMID: 35801072
PMC: 9229364.
DOI: 10.5455/msm.2022.33.40-43.
Human Tissue Kallikreins-Related Peptidases Are Targets for the Treatment of Skin Desquamation Diseases.
Zani M, SantAna A, Tognato R, Chagas J, Puzer L
Front Med (Lausanne). 2022; 8:777619.
PMID: 35356049
PMC: 8959125.
DOI: 10.3389/fmed.2021.777619.
PAD-2-mediated citrullination of nucleophosmin provides an effective target for tumor immunotherapy.
Choudhury R, Symonds P, Paston S, Daniels I, Cook K, Gijon M
J Immunother Cancer. 2022; 10(2).
PMID: 35140112
PMC: 8830261.
DOI: 10.1136/jitc-2021-003526.
Update on the etiopathogenesis of psoriasis (Review).
Branisteanu D, Cojocaru C, Diaconu R, Porumb E, Alexa A, Nicolescu A
Exp Ther Med. 2022; 23(3):201.
PMID: 35126704
PMC: 8794554.
DOI: 10.3892/etm.2022.11124.
Welch-weighted Egger regression reduces false positives due to correlated pleiotropy in Mendelian randomization.
Brown B, Knowles D
Am J Hum Genet. 2021; 108(12):2319-2335.
PMID: 34861175
PMC: 8715134.
DOI: 10.1016/j.ajhg.2021.10.006.
A Michael Acceptor Analogue, SKSI-0412, Down-Regulates Inflammation and Proliferation Factors through Suppressing Signal Transducer and Activator of Transcription 3 Signaling in IL-17A-Induced Human Keratinocyte.
Kim A, Lee S, Shin J, Seok S, Suh Y, Kim D
Int J Mol Sci. 2021; 22(16).
PMID: 34445513
PMC: 8396041.
DOI: 10.3390/ijms22168813.
Affective temperament, depressive symptoms and interleukins in patients with psoriasis.
Marek-Jozefowicz L, Jaracz M, Borkowska A
Postepy Dermatol Alergol. 2021; 38(2):137-143.
PMID: 34408580
PMC: 8362774.
DOI: 10.5114/ada.2021.104289.
Therapeutic Development Based on the Immunopathogenic Mechanisms of Psoriasis.
Tseng J, Chang Y, Huang C, Hsu L, Chuang T
Pharmaceutics. 2021; 13(7).
PMID: 34371756
PMC: 8308930.
DOI: 10.3390/pharmaceutics13071064.
Advanced Characterization of Imiquimod-Induced Psoriasis-Like Mouse Model.
Jabeen M, Boisgard A, Danoy A, El Kholti N, Salvi J, Boulieu R
Pharmaceutics. 2020; 12(9).
PMID: 32825447
PMC: 7558091.
DOI: 10.3390/pharmaceutics12090789.
Ozone therapy promotes the differentiation of basal keratinocytes via increasing Tp63-mediated transcription of KRT10 to improve psoriasis.
Gao L, Dou J, Zhang B, Zeng J, Cheng Q, Lei L
J Cell Mol Med. 2020; 24(8):4819-4829.
PMID: 32168425
PMC: 7176851.
DOI: 10.1111/jcmm.15160.